Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Eukaryotic translation initiation factor 3B regulates pancreatic cancer cell proliferation by interacting with RAB14

ABSTRACT: To study the regulatory role of EIF3B in the proliferation of pancreatic cancer (PC) cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE315038 | GEO | 2025/12/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Eukaryotic translation initiation factor 3B regulates pancreatic cancer cell proliferation by interacting with RAB14

Project description:Eukaryotic translation initiation factor 3B regulates pancreatic cancer cell proliferation by interacting with RAB14

| PRJNA1394900 | ENA

Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation.

Project description: Not available

| S-EPMC2573229 | biostudies-literature

Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.

Project description: Not available

| S-EPMC5190032 | biostudies-literature

Translation elongation can control translation initiation on eukaryotic mRNAs.

Project description: Not available

| S-EPMC3990680 | biostudies-literature

Structural Insights into the Role of Eukaryotic Translation Initiation Factor 3 (eIF3) in Translation Mediated by the Hepatitis C Virus IRES

Project description:Cross-linking mass spectrometry was conducted to determine the positions of the non-core subunits (eIF3b, eIF3d, eIF3g, eIF3i, and eIF3j) of eIF3, that were not observed in cryo-EM densities, during elongation. For this analysis, the HCV IRES-initiated uORF2-stalled 80S ribosome was prepared from the in vitro translation system coupled with transcription, identical to the preparation used for the cryo-EM sample.

2025-11-20 | PXD059272 | JPOST Repository

Eukaryotic translation initiation factor 3 (eIF3) subunit e is essential for embryonic development and cell proliferation.

Project description: Not available

| S-EPMC6070656 | biostudies-literature

Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation.

Project description: Not available

| S-EPMC6120211 | biostudies-literature

Proteomic profiling of pancreatic cyst fluid in patients with pancreatic cystic lesions identifies novel biomarkers of pancreatic cancer risk

Project description:Pancreatic Cancer (PC) has the worst 5-year survival rate of any cancer as of 2024, at just 13%. The late-stage diagnosis of these patients limits their treatment options, further compounding the problem. Early detection of PC, therefore, is the primary concern of most PC research, as it has the potential to make a substantial difference to the treatment and survival of these patients. Pancreatic cystic lesions (PCLs) are fluid-filled sacs, on or inside the pancreas, that have the potential to become premalignant. While some PCLs are completely benign, others have been shown to have malignant potential and could therefore play a role in the progression to PC. Using the 2018 European evidence-based guidelines for pancreatic cystic neoplasms, patients were classified as being either at a low- or high-risk of PC development. In this study, we profile the proteome of pancreatic cyst fluid from low-risk (n=15) and high-risk (n=17) patients with PCLs and identify differentially expressed proteins between these two risk classifications. We show that these PCF-based differentially expressed proteins have potential utility as biomarkers of risk stratification in this setting.

2025-01-06 | PXD057299 | Pride

Protein expression in pancreatic cancer cell lines and normal pancreatic ductal cell line.

Project description:Pancreatic cancer (PC) is the sixth leading cause of cancer-associated death worldwide. Despite improvements in treatment methods, the 5-year survival rate of PC patients is still low. Although carbohydrate antigen (CA) 19-9 has been used as the most specific and sensitive biomarker for the diagnosis of PC, approximately 34% of PC patients may have a Lewis antigen-negative phenotype and secrete little, if any, CA19-9. Therefore, it is important to develop effective diagnostic methods for PC. In this study, we performed a global shotgun proteomics analysis using PC cell lines and a normal pancreatic ductal cell line. We identified 142 candidate proteins with differential expression in PC cells. A label-free semiquantitative method based on spectral counting and Gene Ontology analysis led to a total of 25 candidate proteins that could potentially be detected in blood. Validation studies revealed that the expression of fibulin-1 was lower in PC cells than in normal pancreatic ductal cells. Moreover, in vivo fibulin-1 expression was significantly lower in serum from PC patients than in healthy individuals. These findings suggest that lower blood levels of fibulin-1 may be a novel biomarker for the detection of PC.

2025-12-03 | PXD061294 | JPOST Repository

RIP-seq of translation initiation factors eIF2γ, eIF3b and two RBPs involved in the process of mRNA degradation and storage, Pat1p and Lsm1p

Project description:The aim of this experiment is to determine the RNA binding partners of the translation initiation factors eIF2γ (GCD11), eIF3b (PRT1) and Pat1p and Lsm1p two RNA binding proteins (RBPs) involved in mRNA degradation and storage.

2023-09-06 | E-MTAB-13033 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data